Skip to main content
. 2021 Jul;10(7):1851–1866. doi: 10.21037/tp-21-226

Figure 11.

Figure 11

Relationship between risk score and drug sensitivity based on the R package pRRophetic. Bortezomib (A); cisplatin (B); dasatinib (C); and axitinib (D).